Evidence map›Paper›PMID 42406732›Full record

ArticlePloS one2026

Health-related quality of life and cost-of-illness in young people seeking peer support at @ease: A Dutch burden of disease study.

Anouk Boonstra, Ghislaine A P G van Mastrigt, Silvia M A A Evers, Sander Osstyn, Remco F P de Winter, Nynke Boonstra, @ease consortium, Therese A M J van Amelsvoort, Sophie M J Leijdesdorff

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anouk BoonstraMental Health and Neuroscience (MHeNs) Research Institute, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.ORCID https://orcid.org/0000-0001-7890-9415
Ghislaine A P G van MastrigtCare and Public Health Research Institute (CAPHRI), Department of Health Services Research, Maastricht University, Maastricht, the Netherlands.
Silvia M A A EversCare and Public Health Research Institute (CAPHRI), Department of Health Services Research, Maastricht University, Maastricht, the Netherlands.
Sander OsstynMental Health and Neuroscience (MHeNs) Research Institute, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
Remco F P de WinterMental Health and Neuroscience (MHeNs) Research Institute, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.ORCID https://orcid.org/0000-0003-4129-8440
Nynke BoonstraDepartment of Healthcare, NHL Stenden University of Applied Sciences, Leeuwarden, the Netherlands.
@ease consortium
Therese A M J van AmelsvoortMental Health and Neuroscience (MHeNs) Research Institute, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
Sophie M J LeijdesdorffMental Health and Neuroscience (MHeNs) Research Institute, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe burden of mental health problems remains largely unexplored among vulnerable young people, especially those seeking peer support. Accessing peer support is often a first form of help-seeking, allowing early identification of signs of distress. The lost (mental) health and expenses of these young people upon presenting for peer support can be revealed through monitoring of health-related quality of life (HRQoL) and costs of mental healthcare and productivity loss, examined in this study among young people visiting the @ease peer-to-peer walk-in centres in the Netherlands.

methodsFrom @ease's inception in January 2018 to mid-2024, a total of 940 answered questionnaires gathered through consecutive sampling contained minimally one required item. This bottom-up prevalence-based study focused on youth aged 12-30 who sought peer counselling at @ease. Burden of disease was estimated by: (1) HRQoL (EQ-5D-5L), and (2) Cost-of-illness through school absenteeism and mental healthcare use. Multiple imputation was used before conducting regression analyses, followed by non-parametric bootstrapping. This study expands upon an earlier publication that analysed data up to May 2019.

resultsHRQoL was impaired (M = 0.64, SD = 0.24) and significantly lower if living alone or having parents with mental health problems, and higher if having a higher level of social and occupational functioning. In the three months before presenting, 35.2% of young people had been absent from school (3 days on average, costing €358 per individual) and 33.4% had visited mental healthcare (2 visits on average, costing €234 per individual). Total cost-of-illness was €1,501,743 annually, and €2,318 per individual. Mental healthcare costs were higher for those born in the Netherlands and without occupation, and school absenteeism costs were higher outside the COVID-19 pandemic and if not born in the Netherlands.

conclusionsFound impairments and costs underscore the importance of investing in early-stage low-threshold services where substantial burden is already detectable, and of strengthening their capacity and links to stepped-care pathways to ensure timely support. Initiatives that help improve functioning and aid with challenging contexts may be advantageous in lowering the burden. Prospective (cost-)effectiveness studies are needed.

Indexed as

Cost of IllnessCounselingMental DisordersPeer GroupQuality of LifeSocial SupportAbsenteeismAdolescentAdultChildFemaleHumansMaleMental HealthMental Health ServicesNetherlands

Identifiers

PMID42406732
PMCPMC13336155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.